Forensic quantification of DePuy Attune tibial loosening and early failure claims through 2026 litigation benchmarks.
Active Litigation
Litigation Volume Audited
| Metric | Value |
|---|---|
| Manufacturer | DePuy (J&J) |
| Main Issue | Tibial Loosening |
| Revision Payout | $200K - $500K |
| Injury Class | Avg Settlement |
|---|---|
| Revision Surgery Required | $350,000 |
| Tibial Component Loosening | $300,000 |
| Bone Damage / Cement Failure | $250,000 |
| Parameter | Standard |
|---|---|
| Study Data | Tibial Failure |
| Failure Timing | 2 - 5 Years |
| Audit Version | S-Class v2.6 |
DePuy Attune lawsuits focus on **Tibial Component Loosening**. Our engine audits clinical failure markers including cement-bond data, early-failure timing windows, and revision surgical complexity.
Tibial baseplate separation analysis
Early failure window weighting
Active consolidated claim metrics
"Calibrated against FDA MAUDE reports and Attune-specific tibial loosening clinical studies (2013-2026)."
A: In 2026, average DePuy Attune knee settlements for cases requiring revision surgery range from $200,000 to $500,000. Values depend strictly on the age of the patient, severity of bone damage, and impact on long-term mobility.
A: Studies suggest the Attune tibial baseplate design may not allow proper cement bonding to bone. The cement-bone interface fails, causing loosening and premature failure.
A: You can identify your implant by reviewing your original surgical records or product identification labels. If you experience clicking, pain, or instability, your surgeon can perform an audit of the device's status.
Don't let a defective knee implant dictate your mobility. Initiate your institutional-grade settlement audit.
INITIATE AUDIT NOW